Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
about
Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: data from the gulf registry of acute coronary events.Optimal combination secondary prevention drug treatment and stroke outcomes.Improving health outcomes: innovation, coverage, quality and adherence.Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South KoreaEvaluation of proper prescribing of cardiac medications at hospital discharge for patients with acute coronary syndromes (ACS) in two Lebanese hospitals.Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry.Effective universal health coverage and improved 1-year survival after acute myocardial infarction: the Chilean experience.Evaluation of medication compliance for secondary prevention of acute coronary syndrome.Prediction of persistence of combined evidence-based cardiovascular medications in patients with acute coronary syndrome after hospital discharge using neural networks.Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France.Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study
P2860
Q33850977-887D174A-B106-4FDA-A595-DDB6671B0A50Q35106572-487523B3-2759-413E-B020-D483239C0EA1Q36411429-ADFFB4A7-2D5E-4868-9AD1-52F940BFB7D7Q36593654-512EA9DD-35D3-49F0-827E-2BC683F9FAB7Q37724877-891902F7-7122-43D6-9C90-CEC9164D5F40Q38194089-3509E289-7289-4F4E-8692-D4FD9C801E68Q41044641-3FDB91A1-5946-4903-8B6F-08E00F2B85D8Q41656587-85949477-5514-4C13-8049-EE38001005FBQ44467847-EEEAAE71-7AF6-4F3A-9CCE-988EB7357AA9Q45371516-2B2C60E1-A98F-49D9-AB5D-CFB6FC73919DQ46981071-07225073-C032-43C3-99CB-0C5DCB894A87Q58007726-08B5F74B-76E1-4E4A-B90D-4DA8289FB0C0
P2860
Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Impact of combined secondary p ...... a nationwide French registry.
@ast
Impact of combined secondary p ...... a nationwide French registry.
@en
type
label
Impact of combined secondary p ...... a nationwide French registry.
@ast
Impact of combined secondary p ...... a nationwide French registry.
@en
prefLabel
Impact of combined secondary p ...... a nationwide French registry.
@ast
Impact of combined secondary p ...... a nationwide French registry.
@en
P2093
P1476
Impact of combined secondary p ...... a nationwide French registry.
@en
P2093
Didier Blanchard
Guy Hanania
Jean-Marc Lablanche
Jean-Pierre Cambou
Laurent Vaur
Nathalie Genès
Nicolas Danchin
Pascal Guéret
Pierre Clerson
USIC 2000 investigators
P304
P356
10.1016/J.AHJ.2005.01.058
P407
P577
2005-12-01T00:00:00Z